english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

European fines for anti-generic strategies: when will penalties get tougher?

Prescrire's finances: 2025 annual report

Biotechnologies: proposed European legislation underpinned by a biased approach

A rich exchange

Dexamfetamine (Tentin°) or lisdexamfetamine (Xurta°) in attention deficit hyperactivity disorder

Cerliponase alfa (Brineura°) in neuronal ceroid lipofuscinosis type 2 disease: new data

GLP-1 and dual GLP-1/GIP agonists: ischaemic optic neuropathy

The Prescrire Drug Awards for 2025

Look to the past

Lecanemab (Leqembi°) in early Alzheimer's disease

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90